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Objectives: Neurologic dysfunction is a problem in patients with congenital heart disease. Near-infrared spec-
troscopy may provide a real-time window into cerebral oxygenation. Enthusiasm for near-infrared spectroscopy
has increased hopes of reducing neurologic dysfunction. However, potential gains need to be evaluated relative to
cost before routine implementation. Responding to data in ways that seem intuitively beneficial can be risky when
the long-term impact is unknown. Thus, we performed a systematic review of the literature on near-infrared spec-
troscopy in congenital heart disease.
Methods: A literature search from 1950 to April 2007 for near-infrared spectroscopy in congenital heart disease
was undertaken. We identified 54 manuscripts and\ 13 reviews.
Results: There were 47 case series, 4 randomized trials, and 3 retrospective studies. Two studies had postdi-
scharge follow-up, one incorporating neurologic testing. Neither of these studies demonstrated a benefit. One ret-
rospective study, which included near-infrared spectroscopy and other intraoperative measures of cerebral
perfusion, demonstrated a decrease in neurologic dysfunction using this combination of monitors. Three small
studies were able to correlate near-infrared spectroscopy with other clinical and radiologic findings.
Conclusions: Many centers, and even entire countries, have adopted near-infrared spectroscopy as standard of
care. The available data suggest that multimodality monitoring, including near-infrared spectroscopy, may be
a useful adjunct. The current literature on the use of near-infrared spectroscopy alone, however, does not dem-
onstrate improvement in neurologic outcome. The data correlating near-infrared spectroscopy findings with in-
direct measures of neurologic outcome or mortality are limited. Although near-infrared spectroscopy has
promise for measuring regional tissue oxygen saturation, the lack of data demonstrating improved outcomes
limits the support for widespread implementation.Supplemental material is available online.
Neurologic dysfunction is a significant problem in congeni-
tal heart disease (CHD). Historically, cardiac surgeons and
cardiologists have had significant interest in acute clinical
neurologic abnormalities such as stroke and seizure. With
improved perioperative care, however, the prevalence of
major acute neurologic abnormalities has decreased to 1%
to 2% of open heart cases.1 Of growing concern are late neu-
rodevelopmental and behavioral problems associated with
pediatric cardiac surgery.2 These late neurologic impair-
ments are compounded in children who require multiple
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ing of the impact of long-term neurologic sequelae on qual-
ity of life is crucial. Significant efforts from physicians and
industry have been directed toward developing improved
monitoring techniques for early detection of neurologic
injury in hopes of averting or ameliorating subsequent com-
plications. Current technologies include transcranial Dopp-
ler, electroencephalograms, bispectral index, biomarkers,
and jugular bulb oximetry. Physician enthusiasm has in-
creased for the use of near-infrared spectroscopy (NIRS)
in the perioperative period in hopes of reducing neurologic
dysfunction.
NIRS is based on the differential absorption of varying
wavelengths of light by hemoglobin as it associates with ox-
ygen. It provides a regional measurement of oxygen content
in a localized tissue bed. The device can be used for both ce-
rebral and somatic regional measurements. The value re-
ported represents the amount of oxygen present within the
tissue, including arterioles, capillaries, and venules. The
measurement is venous weighted (85% venous, 15% arte-
rial). The purported value of cerebral NIRS is the ability to
obtain noninvasive, real-time information on the cerebral
oxygen content in the frontal cortex that reflects both oxygen
delivery and consumption. This information may help guide
interventions by the surgical team or intensive care physi-
cians to maintain theoretically safe cerebral oxygenation
levels.gery c January 2009
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CHD ¼ congenital heart disease
MRI ¼ magnetic resonance imaging
NIRS ¼ near-infrared spectroscopy
rScO2 ¼ regional cerebral oxygen saturation
NIRS technology has been described in the adult and pedi-
atric cardiac literature in multiple clinical settings, including
the intensive care unit and operating room. As with any new
technology, the potential clinical gains (and limitations)
need to be critically evaluated before integration into routine
patient care. Each additional monitoring device comes with
an additional cost and with increasing patient care complex-
ity. In addition, responding to data in ways that seem in-
tuitively beneficial can be risky when the long- or even
intermediate-term impact on clinical outcomes is unknown.
Within this context, we conducted a systematic review of the
scientific literature to examine the available evidence for the
use of NIRS in the care of patients with CHD.
METHODS
Eligibility Criteria
Inclusion criteria for the literature search were limited to human studies,
English language, and pediatric cardiac patients; all such manuscripts using
NIRS in any area of pediatric cardiology and pediatric cardiac surgery were
included. Editorials, case reports, and duplicates were excluded. We re-
viewed narrative reviews of the use of NIRS in pediatric cardiac patients
to avoid publication bias and to highlight the key difference between sys-
tematic and narrative reviews. The content of the narrative reviews was
not included, as is customary, in the formal systematic review as it does
not represent a primary scientific manuscript. All references were evaluated
from the manuscripts to confirm inclusion of all pertinent studies.
Search Strategy
We searched the English language literature about the use of NIRS in the
pediatric cardiac population from 1950 to April 2007 with MEDLINE, Pre-
MEDLINE, EMBASE, and Cochrane databases. The MEDLINE search
was performed combining the key word search: near infrared spectros-
copy, NIRS, or infrared spectroscopy. This list was combined with a key-
word search including the following: pediatric cardiac surgery, CHD,
pediatric, pediatric cardiology, intensive care, ICU, cardiopulmonary by-
pass, CPB, hypothermic circulatory arrest, or DHCA. The results of the
MEDLINE search are outlined in Figure 1. We identified a total of 224
manuscripts and we reviewed all abstracts. Manuscripts were excluded
on adult patients, noncardiac patients, non-English language, editorials, sin-
gle case reports, and duplicates. After these exclusions, a total of 48 man-
uscripts remained with an additional 8 manuscripts identified from the
references of the narrative reviews. Further, we evaluated all articles clas-
sified as narrative review articles involving the patient population of interest
along with their references to confirm an exhaustive review of the scientific
literature.
Data Review and Analysis
We created a standardized data retrieval form. A single reviewer (J.C.H.)
extracted data from the manuscripts and assessed clinical study site, study
design, patient population, sample size, mode of monitoring, NIRS device,
primary and secondary outcomes, intervention if any, and follow-up. WeThe Journal of Thoracic and Csubclassified manuscripts into general clinical sites for review and compila-
tion (Figure 2). It was not possible to perform a meaningful meta-analysis
with generation of a summary statistic owing to variation in end points,
study design, monitoring device, and statistical analyses.
RESULTS
We identified 56 manuscripts that fit the eligibility criteria
(Figure 1). We also identified and reviewed an additional 13
narrative review articles for comparative purposes. For sim-
plicity of evaluation, we sorted the manuscripts by the clin-
ical setting (Figure 2). Of the 13 review articles, 4 narrative
reviews specifically focused on NIRS in the care of patients
undergoing pediatric cardiac surgery.3-6 These review arti-
cles were not inclusive of all the potential clinical settings.
The median number of manuscripts referenced within the re-
view articles on NIRS and CHD patients was 8.5.3-15
The primary research manuscripts evaluated 6 different
devices: INVOS (Somanetics, Troy, Mich), NIRO (Hama-
matsu Photonics, Hamamatsu City, Japan), NIMS (NIMS
Inc, Philadelphia, Pa), Radiometer (Copenhagen, Denmark),
PSA-3N (Biomedical Science, Kanazawa, Japan), and In-
spectra Tissue Spectrometer (Hutchinson Technology,
Hutchinson, Minn). Owing to the natural progression of de-
vice technology, one can observe multiple models of the
INVOS and NIRO devices evaluated in the literature. Vari-
ous devices use different terminology to refer to cerebral ox-
ygen content (Table 1).
Intraoperative Monitoring
A total of 38 manuscripts involved the use of NIRS in the
intraoperative setting. The manuscripts were subdivided into
8 categories for summative purposes (Figure 3). Table E1
shows the author, year of publication, study design, monitor-
ing device, patient population, number of patients, primary
end point, and results. The manuscripts include 31 case se-
ries, 4 randomized trials, and 3 retrospective studies. The
median sample size was 20 (range, 9–250). Two of the 38
manuscripts (in fact, the only 2 of the 56 overall manuscripts)
had planned follow-up after hospital discharge; these follow-
ups occurred at 3 months.16,17 One retrospective study as-
sessed the role of an interventional algorithm on neurologic
outcomes.18 They found that in patients with postoperative
neurologic changes, more had noteworthy intraoperative
cerebral perfusion changes (defined as a 50% decrease in ce-
rebral blood flow by transcrianial Doppler, excessive electro-
encephalographic slowing, or a decrease in regional cerebral
oxygen saturation [rScO2] by NIRS of>20% for 3 minutes)
that were not intervened on with a predetermined algorithm
(P ¼ .003).18 Three manuscripts evaluated the association
of NIRS findings with direct clinical outcomes.19-21 One ret-
rospective study (n ¼ 34) demonstrated that patients who
died after a single ventricle first-stage palliation had lower
rScO2 at the end of the operation (P ¼ .01), but with no cor-
relation to clinical neurologic abnormalities.22 Two caseardiovascular Surgery c Volume 137, Number 1 155
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OR infrared spectroscopy”
8308 Citations Identified
“pediatric cardiac surgery OR congenital heart disease
OR pediatric OR pediatric cardiology”
114,842 Citations Identified
“intensive care OR ICU OR cardiopulmonary bypass
OR CPB OR hypothermic circulatory arrest OR DHCA
100,080 Citations Identified
OR
207,943 Citations Identified
And
261 Citations Identified
224 Citations Identified
Limited to Humans
48 Manuscripts
All abstracts reviewed. See exclusion criteria*
56 Manuscripts
Additional manuscripts obtained from review of references (8)
13 Review articles
FIGURE 1. Search strategy and study selection for inclusion. *Exclusion criteria: adult patients, non-English, noncardiac patients, editorials, case reports,
and duplicates.series correlated intraoperative NIRS measurements with
postoperative magnetic resonance imaging (MRI) find-
ings.19,21 One (n ¼ 16)21 demonstrated that decreased
rScO2 during aortic crossclamping in patients was associated
with abnormal postoperativeMRIs (P¼ .08). The other (n¼
22)19 found that prolonged low postoperative rScO2 less than
45% for more than 180 minutes was associated with either
new or worsening lesions on postoperative MRI (P ¼ .029).
Intensive Care Unit Monitoring
Eleven manuscripts were identified that described the use
of NIRS in the intensive care unit for patients with CHD. All
of these manuscripts were case series, with a median sample
size of 15 (range, 5–110). No studies contained neurologic
follow-up assessments, nor did they correlate NIRS findings
with clinical outcomes. Table E2 shows the author, year of
publication, study design, monitoring device, patient popu-
56
Manuscripts
38
Intra-operative
Monitoring
11
Intensive Care
Monitoring
7
Catheterization
Lab Monitoring
FIGURE 2. Classification of included manuscripts based on clinical appli-
cation.156 The Journal of Thoracic and Cardiovascular Surlation, number of patients, primary end point, and results.
Three studies focused on preoperative monitoring to define
baseline values23 and the response to hypoxia24 and hyper-
carbia.25 Seven studies focused on postoperative intensive
care monitoring. These studies sought to correlate NIRS
measurements with somatic NIRS measurements,26,27 alter-
ations in ventilator management,28,29 sildenafil use,30 and
global measurements of systemic oxygenation.31,32 They
identified correlations between rScO2 and various traditional
hemodynamic parameters (mean and systemic arterial pres-
sure, arterial saturation, and mixed venous saturation). One
study incorporated NIRS monitoring for single ventricle pa-
tients after stage 1 palliation on temporary ventricular assist
devices. That study demonstrated a significant decrease in
rScO2 after the discontinuation of cardiopulmonary bypass.
The decreased rScO2 did not normalize for 48 hours despite
normalization of other standard measurements such as lac-
tate and mean arterial pressure.33 The overarching findings
in all of the studies were the presence of large interindividual
variability and intraindividual temporal variability, which
makes direct comparisons or determination of discrete safety
measurements difficult.
Cardiac Catheterization Laboratory
Seven manuscripts were identified that described the use
of NIRS for patients with CHD in the catheterization labora-
tory. All of these manuscripts were case series, with amedian
sample size of 29 (range, 11–98). None of these studies con-
tained neurologic follow-up or correlated NIRS findings
with clinical outcomes. Table E3 shows the author, year of
publication, study design, monitoring device, patientgery c January 2009
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Device Measurement Abbreviation
INVOS Regional oxygen saturation (cerebral or somatic) rScO2 or rSO2
NIRO Tissue oxygenation (oxyhemoglobin and deoxyhemoglobin), cellular
oxygenation based on the oxidized state of cytochrome aa3 and the
tissue oxygenation index
oxyHgb, deoxyHgb, total Hgb, Cytaa3, TOI
NIMS Regional cerebral oxygen saturation ScO2
Radiometer Tissue oxygenation (oxyhemoglobin and deoxyhemoglobin), cellular
oxygenation based on the oxidized state of cytochrome aa3
HbO2, Hb, cyt O2
PSA-3N Regional cerebral hemoglobin oxygen saturation SrO2
Inspectra tissue spectrometer Tissue saturation STO2C
H
Dpopulation, number of patients, primary end point, and re-
sults. As with the studies in the intensive care unit, many
studies attempted to correlate NIRS findings with standard
measurements of global oxygenation.34-38 One study corre-
lated alterations in regional and global saturation with alter-
ations in ventilation.39 A second manuscript reported on the
effect of balloon inflation during balloon dilation procedures
in patients with and without intracardiac shunts. This study
found that rScO2 decreases with balloon inflation in patients
with intracardiac shunts and that the recovery time is directly
related to inflation time.40 As with the studies in the inten-
sive care unit, significant interindividual variability existed,
making it difficult to compare patients.
CONCLUSIONS
Systematic reviews allow for a ‘‘pause’’ in the process of
conducting research. They demonstrate, based on the avail-
able evidence, what we do know about a specific question.
This information is then used to direct future research studies
to clarify the areas of uncertainty. Systematic reviews follow
a prospectively defined protocol to identify and appraise the
relevant evidence. This is important in minimizing publica-
tion and information bias, which sets this methodology apart
from traditional narrative reviews. Systematic reviews are
limited by the quality of the original research being reviewed
38
Manuscripts
1
Anesthesia
2
Aortic Coarctation
Repair
5
Deep Hypothermia
with and without
circulatory arrest
12
Intra-operative
monitoring
8
Regional low flow
perfusion
6
Perfusion
techniques
1
Monitoring
technique
3
Pre/Intra/Post-
operative Monitoring
FIGURE 3. Classification of NIRS monitoring in the operating room.The Journal of Thoracic and Cand do not represent primary data. In addition, negative stud-
ies often do not reach publication, which can favor the treat-
ment. Meta-analyses represent a type of systematic review
that involves formal quantitative analyses of the summarized
information. Meta-analyses require similar methodologies
and outcomes measures for a summary statistic. With the
wide variability in devices, small sample size, and variable
end points, this was not possible with the available literature.
Owing to the strength of minimizing bias, systematic re-
views play an important role in clinical and health care pol-
icy decision-making.
Many centers, and even entire countries, have adopted
NIRS as a standard of care (forum discussion at 2007 Con-
genital Heart Surgeons Society Meeting). Yet, no level I
evidence-based medical research has been published to indi-
cate that clinical decision-making based on NIRS data is
beneficial to the patient. Although the continued desire to
mitigate the neurologic complications associated with
CHD and its surgical intervention is laudable, the role for
NIRS in meeting that goal remains clouded by the lack of re-
liable scientific evidence.
This study provides a comprehensive review of the scien-
tific literature on NIRS for patients with CHD. The majority
of studies reporting on NIRS for this patient population are
limited by their case series design, with no appropriate com-
parison groups, and with small sample sizes. In addition, the
NIRS technology has changed significantly since its incep-
tion. The literature reflects these changes over time with 6
different NIRS technologies represented in articles we re-
viewed. Although all of the devices are based on the same
theoretical premise of the monitoring of regional oxygena-
tion, they employ various measurement indices, making it
difficult to cull the data from multiple studies for compari-
son. The significant variability in NIRS measurements, tem-
porally and between individual patients, precludes the
establishment of absolute threshold values for tissue ische-
mia. Relative values and individual patient trends have
been used rather than absolute values. However, there is
only limited evidence to indicate that these correlate with
clinical outcomes.18,41 Furthermore, the wide heterogeneity
in anatomy and physiology in CHD patients results inardiovascular Surgery c Volume 137, Number 1 157
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the small sample sizes, the diverse patient populations stud-
ied cause extrapolation to the overall CHD population to be
challenging, if not impossible.
The available data suggest that multimodality monitoring
of cerebral perfusion, including NIRS, may be a useful ad-
junct to prevent neurologic injury.18 The current literature
on the use of NIRS alone for CHD patients does not demon-
strate a clinical improvement in short-term neurologic out-
come. There are no prospective data evaluating NIRS
findings with direct clinical outcomes. The data correlating
NIRS findings with indirect measures of neurologic out-
come, such as MRI or mortality, are also limited.19,21,22
In assessing the potential role of NIRS monitoring in
CHD, it is important to emphasize its unique qualities, in-
cluding noninvasive, continuous, and real-time measure-
ment of regional tissue oxygen saturation. However,
caution must be exercised in extrapolating regional measure-
ments to global findings. For example, alterations in regional
oxygen saturation may reflect local changes and not neces-
sarily indicate global hypoperfusion. Conversely, regional
changes in oxygenation may be earlier, more sensitive indi-
cators of impending multisystem organ injury. To date, no
study has validated the correlation of NIRS measurements
with other measurements of low cardiac output states. This
is an important distinction when analyzing the literature in
that reports of low regional cerebral oxygenation measure-
ments do not necessarily indicate a low cardiac output state
or global altered cerebral perfusion.
Future research needs to focus on how the addition of this
regional oxygen saturation adds value to the clinical setting,
rather than attempts to correlate NIRS with previously estab-
lished global measurements of perfusion. Most important,
before universal implementation of this technology, it is es-
sential that rigorous clinical trials be performed to demon-
strate improved clinical outcomes with the addition of
NIRS monitoring.
References
1. Menache´ CC, du Plessis AJ, Wessel DL, Jonas RA, Newburger JW. Current in-
cidence of acute neurologic complications after open-heart operations in children.
Ann Thorac Surg. 2002;73:1752-8.
2. Shillingford AJ, Wernovsky G. Academic performance and behavioral difficulties
after neonatal and infant heart surgery.Pediatr ClinNorthAm. 2004;51:1625-39, ix.
3. Ghanayem NS, Mitchell ME, Tweddell JS, Hoffman GM. Monitoring the brain
before, during, and after cardiac surgery to improve long-term neurodevelopmen-
tal outcomes. Cardiol Young. 2006;16(Suppl. 3):103-9.
4. Hoffman GM. Detection and prevention of neurologic injury in the intensive care
unit. Cardiol Young. 2005;15(Suppl. 1):149-53.
5. Andropoulos DB, Stayer SA, Diaz LK, Ramamoorthy C. Neurological monitoring
for congenital heart surgery. Anesth Analg. 2004;99:1365-75; table of contents.
6. Fraser CD Jr, Andropoulos DB. Neurologic monitoring for special cardiopulmo-
nary bypass techniques. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu.
2004;7:125-32.
7. Hoffman GM. Pro: near-infrared spectroscopy should be used for all cardiopul-
monary bypass. J Cardiothorac Vasc Anesth. 2006;20:606-12.
8. Hoffman GM. Neurologic monitoring on cardiopulmonary bypass: what are we
obligated to do? Ann Thorac Surg. 2006;81:S2373-80.158 The Journal of Thoracic and Cardiovascular Sur9. Wolfberg AJ, du Plessis AJ. Near-infrared spectroscopy in the fetus and neonate.
Clin Perinatol. 2006;33:707-28, viii.
10. Lozano S, Mossad E. Cerebral function monitors during pediatric cardiac surgery:
can they make a difference? J Cardiothorac Vasc Anesth. 2004;18:645-56.
11. Zimmerman AT, Ibsen LM. Advances in postoperative care of pediatric cardiac
patients. Curr Opin Anesthesiol. 2004;17:241-6.
12. Soul JS, du Plessis AJ. New technologies in pediatric neurology. Near-infrared
spectroscopy. Semin Pediatr Neurol. 1999;6:101-10.
13. Golej J, Trittenwein G. Early detection of neurologic injury and issues of rehabil-
itation after pediatric cardiac extracorporeal membrane oxygenation. Artif Or-
gans. 1999;23:1020-5.
14. Nollert G, Shin’oka T, Jonas RA. Near-infrared spectrophotometry of the brain in
cardiovascular surgery. Thorac Cardiovasc Surg. 1998;46:167-75.
15. du Plessis AJ. Near-infrared spectroscopy for the in vivo study of cerebral hemo-
dynamics and oxygenation. Curr Opin Pediatr. 1995;7:632-9.
16. LeBlanc JG, Blackstock D, Macnab AJ, Gagnon F, Gagnon R, Russell J, et al.
Effects of propofol on cerebral oxygenation during cardiopulmonary bypass in
children. Can J Anaesth. 2000;47:1082-9.
17. ToetMC, FlintermanA,Laar I,Vries JW,BenninkGB,UiterwaalCS, et al. Cerebral
oxygen saturation and electrical brain activity before, during, and up to 36hours after
arterial switch procedure in neonateswithout pre-existing brain damage: its relation-
ship to neurodevelopmental outcome. Exp Brain Res. 2005;165:343-50.
18. Austin EH 3rd, Edmonds HL Jr, Auden SM, Seremet V, Niznik G, Sehic A, et al.
Benefit of neurophysiologic monitoring for pediatric cardiac surgery. J Thorac
Cardiovasc Surg. 1997;114:707-15, 717; discussion 715-6.
19. Dent CL, Spaeth JP, Jones BV, Schwartz SM, Glauser TA, Hallinan B, et al. Brain
magnetic resonance imaging abnormalities after the Norwood procedure using re-
gional cerebral perfusion. J Thorac Cardiovasc Surg. 2006;131:190-7.
20. Fenton KN, Freeman K, Glogowski K, Fogg S, Duncan KF. The significance of
baseline cerebral oxygen saturation in children undergoing congenital heart sur-
gery. Am J Surg. 2005;190:260-3.
21. McQuillen PS, Barkovich AJ, Hamrick SE, Perez M, Ward P, Glidden DV, et al.
Temporal and anatomic risk profile of brain injury with neonatal repair of congen-
ital heart defects. Stroke. 2007;38(2 Suppl):736-41.
22. Fenton KN, Lessman K, Glogowski K, Fogg S, Duncan KF. Cerebral oxygen sat-
uration does not normalize until after stage 2 single ventricle palliation. Ann
Thorac Surg. 2007;83:1431-6.
23. Kurth CD, Steven JL, Montenegro LM, Watzman HM, Gaynor JW, Spray TL,
et al. Cerebral oxygen saturation before congenital heart surgery. Ann Thorac
Surg. 2001;72:187-92.
24. Takami T, Yamamura H, Inai K, Nishikawa Y, Takei Y, Hoshika A, et al. Mon-
itoring of cerebral oxygenation during hypoxic gas management in congenital
heart disease with increased pulmonary blood flow. Pediatr Res. 2005;58:521-4.
25. RamamoorthyC,TabbuttS,KurthCD,StevenJM,MontenegroLM,DurningS,et al.
Effects of inspired hypoxic and hypercapnic gas mixtures on cerebral oxygen satura-
tion in neonates with univentricular heart defects. Anesthesiology. 2002;96:283-8.
26. McQuillen PS, Nishimoto MS, Bottrell CL, Fineman LD, Hamrick SE,
Glidden DV, et al. Regional and central venous oxygen saturation monitoring fol-
lowing pediatric cardiac surgery: concordance and association with clinical vari-
ables. Pediatr Crit Care Med. 2007;8:154-60.
27. Li J, VanArsdell GS, ZhangG,Cai S, Humpl T, CaldaroneCA, et al. Assessment of
the relationship between cerebral and splanchnic oxygen saturations measured by
near-infrared spectroscopy anddirectmeasurements of systemic haemodynamicvar-
iables and oxygen transport after the Norwood procedure.Heart. 2006;92:1678-85.
28. Mott AR, Alomrani A, Tortoriello TA, Perles Z, East DL, Stayer SA. Changes in
cerebral saturation profile in response to mechanical ventilation alterations in in-
fants with bidirectional superior cavopulmonary connection. Pediatr Crit Care
Med. 2006;7:346-50.
29. Bassan H, Gauvreau K, Newburger JW, Tsuji M, Limperopoulos C, Soul JS, et al.
Identification of pressure passive cerebral perfusion and its mediators after infant
cardiac surgery. Pediatr Res. 2005;57:35-41.
30. Nagdyman N, Fleck T, Bitterling B, Ewert P, Abdul-Khaliq H, Stiller B, et al. In-
fluence of intravenous sildenafil on cerebral oxygenation measured by near-infra-
red spectroscopy in infants after cardiac surgery. Pediatr Res. 2006;59:462-5.
31. Tortoriello TA, Stayer SA,Mott AR,McKenzie ED, Fraser CD, Andropoulos DB,
et al. A noninvasive estimation of mixed venous oxygen saturation using near-in-
frared spectroscopy by cerebral oximetry in pediatric cardiac surgery patients.
Paediatr Anaesth. 2005;15:495-503.
32. Nagdyman N, Fleck T, Barth S, Abdul-Khaliq H, Stiller B, Ewert P, et al. Relation
of cerebral tissue oxygenation index to central venous oxygen saturation in chil-
dren. Intensive Care Med. 2004;30:468-71.gery c January 2009
Hirsch et al Congenital Heart Disease33. Giacomuzzi C, Heller E, Mejak B, You J, Ungerleider R, SilberbachM. Assessing
the brain using near-infrared spectroscopy during postoperative ventricular cir-
culatory support. Cardiol Young. 2005;15(Suppl. 1):154-8.
34. Bhutta AT, Ford JW, Parker JG, Prodhan P, Fontenot EE, Seib PM, et al. Nonin-
vasive cerebral oximeter as a surrogate for mixed venous saturation in children.
Pediatr Cardiol. 2007;28:34-41.
35. Levy RJ, Stern WB, Minger KI, Montenegro LM, Ravishankar C, Rome JJ, et al.
Evaluation of tissue saturation as a noninvasive measure of mixed venous satura-
tion in children. Pediatr Crit Care Med. 2005;6:671-5.
36. Nagdyman N, Fleck T, Schubert S, Ewert P, Peters B, Lange PE, et al. Compar-
ison between cerebral tissue oxygenation index measured by near-infrared spec-
troscopy and venous jugular bulb saturation in children. Intensive Care Med.
2005;31:846-50.The Journal of Thoracic and C37. Daubeney PE, Pilkington SN, Janke E, Charlton GA, Smith DC, Webber SA. Ce-
rebral oxygenation measured by near-infrared spectroscopy: comparison with jug-
ular bulb oximetry. Ann Thorac Surg. 1996;61:930-4.
38. Kirshbom PM, Forbess JM, Kogon BE, Simsic JM, Kim DW, Raviele AA, et al.
Cerebral near infrared spectroscopy is a reliable marker of systemic perfusion in
awake single ventricle children. Pediatr Cardiol. 2007;28:42-5.
39. WatzmanHM, Kurth CD,Montenegro LM, Rome J, Steven JM, Nicolson SC. Ar-
terial and venous contributions to near-infrared cerebral oximetry. Anesthesiol-
ogy. 2000;93:947-53.
40. de Vries JW, Hoorntje TM, Sreeram N. Neurophysiological effects of pediatric
balloon dilatation procedures. Pediatr Cardiol. 2000;21:461-4.
41. Kurth CD, Steven JM, Nicolson SC. Cerebral oxygenation during pediatric cardiac
surgery using deep hypothermic circulatory arrest. Anesthesiology. 1995;82:74-82.C
H
Dardiovascular Surgery c Volume 137, Number 1 159
Congenital Heart Disease Hirsch et al
C
H
DE-References
E42. Berens RJ, Stuth EA, Robertson FA, Jaquiss RD, Hoffman GM, Troshynski TJ,
et al. Near infrared spectroscopy monitoring during pediatric aortic coarctation
repair. Paediatr Anaesth. 2006;16:777-81.
E43. Azakie A, Muse J, Gardner M, Skidmore KL, Miller SP, Karl TR, et al. Cerebral
oxygen balance is impaired during repair of aortic coarctation in infants and chil-
dren. J Thorac Cardiovasc Surg. 2005;130:830-6.
E44. Kussman BD, Wypij D, DiNardo JA, Newburger J, Jonas RA, Bartlett J, et al.
An evaluation of bilateral monitoring of cerebral oxygen saturation during pedi-
atric cardiac surgery. Anesth Analg. 2005;101:1294-300.
E45. du Plessis AJ, Newburger J, Jonas RA, Hickey P, Naruse H, Tsuji M, et al. Ce-
rebral oxygen supply and utilization during infant cardiac surgery. Ann Neurol.
1995;37:488-97.
E46. Kurth CD, Steven JM, Nicolson SC, Chance B, Delivoria-Papadopoulos M. Ki-
netics of cerebral deoxygenation during deep hypothermic circulatory arrest in
neonates. Anesthesiology. 1992;77:656-61.
E47. Greeley WJ, Bracey VA, Ungerleider RM, Greibel JA, Kern FH, Boyd JL, et al.
Recovery of cerebral metabolism and mitochondrial oxidation state is delayed
after hypothermic circulatory arrest. Circulation. 1991;84(5 Suppl):III400-6.
E48. Hofer A, Haizinger B, Geiselseder G, Mair R, Rehak P, Gombotz H. Monitoring
of selective antegrade cerebral perfusion using near infrared spectroscopy in
neonatal aortic arch surgery. Eur J Anaesthesiol. 2005;22:293-8.
E49. Andropoulos DB, Diaz LK, Fraser CD Jr, McKenzie ED, Stayer SA. Is bilateral
monitoring of cerebral oxygen saturation necessary during neonatal aortic arch
reconstruction? Anesth Analg. 2004;98:1267-72, table of contents.
E50. Hoffman GM, Stuth EA, Jaquiss RD, Vanderwal PL, Staudt SR, Troshynski TJ,
et al. Changes in cerebral and somatic oxygenation during stage 1 palliation of
hypoplastic left heart syndrome using continuous regional cerebral perfusion.
J Thorac Cardiovasc Surg. 2004;127:223-33.
E51. Kilpack VD, Stayer SA, McKenzie ED, Fraser CD Jr, Andropoulos DB. Limit-
ing circulatory arrest using regional low flow perfusion. J Extra Corpor Technol.
2004;36:133-8.
E52. Andropoulos DB, Stayer SA, McKenzie ED, Fraser CD Jr. Novel cerebral phys-
iologic monitoring to guide low-flow cerebral perfusion during neonatal aortic
arch reconstruction. J Thorac Cardiovasc Surg. 2003;125:491-9.
E53. Andropoulos DB, Stayer SA, McKenzie ED, Fraser CD Jr. Regional low-flow
perfusion provides comparable blood flow and oxygenation to both cerebral
hemispheres during neonatal aortic arch reconstruction. J Thorac Cardiovasc
Surg. 2003;126:1712-7.
E54. Pigula FA, Gandhi SK, Siewers RD, Davis PJ, Webber SA, Nemoto EM. Re-
gional low-flow perfusion provides somatic circulatory support during neonatal
aortic arch surgery. Ann Thorac Surg. 2001;72:401-6; discussion 406-7.
E55. Pigula FA, Nemoto EM, Griffith BP, Siewers RD. Regional low-flow perfusion
provides cerebral circulatory support during neonatal aortic arch reconstruction.
J Thorac Cardiovasc Surg. 2000;119:331-9.
E56. Han SH, Kim CS, Kim SD, Bahk JH, Park YS. The effect of bloodless pump
prime on cerebral oxygenation in paediatric patients. Acta Anaesthesiol Scand.
2004;48:648-52.159.e1 The Journal of Thoracic and Cardiovascular SurgE57. Sakamato T, KurosawaH, Shin’oka T, AokiM, Isomatsu Y. The influence of pH
strategy on cerebral and collateral circulation during hypothermic cardiopulmo-
nary bypass in cyanotic patients with heart disease: Results of a randomized trial
and real-time Monitoring. J Thorac Cardiovasc Surg. 2004;127:12-9.
E58. Shaaban Ali M, Harmer M, Elliott M, Thomas AL, Kirkham F. A pilot study of
evaluation of cerebral function by S100beta protein and near-infrared spectros-
copy during cold and warm cardiopulmonary bypass in infants and children un-
dergoing open-heart surgery. Anaesthesia. 2004;59:20-6.
E59. Wardle SP, Yoxall CW,Weindling AM. Cerebral oxygenation during cardiopul-
monary bypass. Arch Dis Child. 1998;78:26-32.
E60. ChowG,Roberts IG, EdwardsAD, Lloyd-ThomasA,WadeA, ElliottMJ, et al. The
relation between pump flow rate and pulsatility on cerebral hemodynamics during
pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg.1997;114:568-77.
E61. Kurth CD, Steven JM, Nicolson SC, Jacobs ML. Cerebral oxygenation during
cardiopulmonary bypass in children. J Thorac Cardiovasc Surg.1997;113:
71-8; discussion 78-9.
E62. Murayama H, Tamaki S, Usui A, Ueda Y.Measurement of cerebral-oxygenation
status when commencing cardiopulmonary bypass in pediatric open-heart sur-
gery. Ann Thorac Cardiovasc Surg. 2006;12:105-12.
E63. Hayashida M, Kin N, Tomioka T, Orii R, Sekiyama H, Usui H, et al. Cerebral
ischaemia during cardiac surgery in children detected by combined monitoring
of BIS and near-infrared spectroscopy. Br J Anaesth. 2004;92:662-9.
E64. Morimoto Y, Niida Y, Hisano K, Hua Y, Kemmotsu O, Murashita T, et al.
Changes in cerebral oxygenation in children undergoing surgical repair of ven-
tricular septal defects. Anaesthesia. 2003;58:77-83.
E65. Daubeney PE, Smith DC, Pilkington SN, Lamb RK, Monro JL, Tsang VT, et al.
Cerebral oxygenation during paediatric cardiac surgery: identification of vulner-
able periods using near infrared spectroscopy. Eur J Cardiothorac Surg.
1998;13:370-7.
E66. Chow G, Roberts IG, Fallon P, Onoe M, Lloyd-Thomas A, Elliott MJ, et al. The
relation between arterial oxygen tension and cerebral blood flow during cardio-
pulmonary bypass. Eur J Cardiothorac Surg. 1997;11:633-9.
E67. VanBel F, ZeeuwePE,Dorrepaal CA,BendersMJ,Van deBorM,Hardjowijono
R. Changes in cerebral hemodynamics and oxygenation during hypothermic car-
diopulmonary bypass in neonates and infants. Biol Neonate. 1996;70:141-54.
E68. Fallon P, Roberts IG, Kirkham FJ, Edwards AD, Lloyd-Thomas A, Elliott MJ.
Cerebral blood volume response to changes in carbon dioxide tension before and
during cardiopulmonary bypass in children, investigated by near infrared spec-
troscopy. Eur J Cardiothorac Surg. 1994;8:130-4.
E69. Skov L, Greisen G. Apparent cerebral cytochrome aa3 reduction during cardio-
pulmonary bypass in hypoxaemic children with congenital heart disease. A crit-
ical analysis of in vivo near-infrared spectrophotometric data. Physiol. Meas.
1994;15:447-57.
E70. Fallon P, Roberts I, Kirkham FJ, Elliott MJ, Lloyd-Thomas A, Maynard R, et al.
Cerebral hemodynamics during cardiopulmonary bypass in children using near-
infrared spectroscopy. Ann Thorac Surg. 1993;56:1473-7.
E71. Roberts IG, Fallon P, Kirkham FJ, Kirshbom PM, Cooper CE, Elliott MJ, et al.
Measurement of cerebral blood flow during cardiopulmonary bypass with near-
infrared spectroscopy. J Thorac Cardiovasc Surg.1998;115:94-102.ery c January 2009
TABLE E1. NIRS monitoring in the operating room
Author Year Study design* Device Patient population Total number Primary end point Results
e redox
eurologic
Propofol has similar effects on
Cytaa3 as hypothermia; no
gross neurologic
complications.
regional
rSO2 with
The decrease in somatic rSO2 with
XC is less in children than
neonates and infants (P< .01),
significant increase in cerebral
rScO2 during XC in children
>1 year.
ic
t
oxygen
Significant decrease in oxyHgb–
deoxyHgb between the right
and left (P ¼ .03), significant
decrease in oxyHgb–deoxyHgb
with nitroprusside (P< .001).
in
rement of
rmicCPB.
No difference between right and
left rScO2 measurements
irrespective of CA
rebral Median time to nadir of oxyHgb
during CA was 25 minutes,
increased total Hgb and
oxyHgb above baseline with
rewarming (P< .001) with
delayed Cytaa3 recovery,
dissociation between
intravascular and
mitochondrial oxygenation
more pronounced in patients
>2 weeks
intraop
tes,
are these
ith postop
n
The half life of rScO2 during CA is
longer for neonate> infants>
children (P< .001), patients
with neurologic complications
had less of an increase in rScO2
on CPB and a significantly
shorter cooling time pre-CA
(P< .05), no significant
difference in rScO2 between
groups
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l
H
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rt
D
isea
seAnesthesia
LeBlanc et al16 2000 Randomized NIRO Elective ASD or VSD with
(n ¼ 11) or without
(n ¼ 13) propofol
24 Effect of propofol on th
status of Cytaa3 and n
complications.
Coarcatation repair
Berens et alE42 2006 Case series INVOS Aortic coarctation repair
via left thoracotomy
26 Describe the changes in
cerebral and somatic
aortic XC.
Azakie et alE43 2005 Case series NIRO Aortic coarctation repair
via left thoracotomy
18 Determine whether aort
occlusion impairs lef
hemispheric cerebral
balance.
Deep hypothermia with and without circulatory arrest (CA)
Kussman et alE44 2005 Case series INVOS Infant biventricular repair
(no arch reconstruction)
62 Evaluate the differences
bihemispheric measu
rScO2 during hypothe
du Plessis et alE45 1995 Case series NIRO Infant biventricular repair
with low flow or CA
63 Relationship between ce
oxyHgb and Cytaa3
Kurth et al41 1995 Case series NIMS Repair or palliation using CA 26 Variation in changes of
rScO2 between neona
infants, children and
changes associated w
neurologic dysfunctio
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TABLE E1. Continued
nt Results
eonates OxyHgb increases during cooling
(P< .05), decreases during CA
in a curvilinear distribution
until a plateau at 40 minutes
(P< .001), and returns to
baseline with rewarming
RO2 and OxyHgb and Cytaa3 decreased
during CA, CMRO2 and Cytaa3
remained lower than baseline
after CPB with CA but returned
to normal in non-CA patients
(P< .01).
IRS
FP with
There was a significant decrease in
bilateral rScO2 and jugular SvO2
with decreasing RLFP rates
(P< .001). Wide interindivi-
dual variation in rScO2.
IRS
FP
ith TCD.
During RLFP, correlation between
hemispheres was poor and only
partially returned to baseline
after RLFP with the left side
always being the lower value.
bral and
uring
O2 and
rScO2 was maintained during
RLFP but decreased below
baseline after CPB. There was
no correlation between cerebral
and somatic oxygenation at any
time point.
e of
LFP
ted for
No difference in rScO2 on full flow
CPB, RLFP, and resumption of
full flow CPB. However, CPB
flow was adjusted to maintain
value within 10% of baseline.
CBFV
rScO2 as
during
Poor correlation between MAP
and required CPB flow. 14/34
had rScO2>95% during RLFP
increasing the risk of
hyperperfusion. No outcomes
correlation for the addition of
CBFV to rScO2 to guide CPB
flow.
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D
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irsch
et
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1
5
CHDAuthor Year Study design* Device Patient population Total number Primary end poi
Kurth et alE46 1992 Case series NIMS Neonates undergoing surgery
with CA
17 Kinetics of oxyHgb in n
during DHCA
Greeley et alE47 1991 Case series NIRO Deep hypothermia with
or without CA in neonates
and children
15 The effect of CA on CM
oxygenation
Regional low flow perfusion (RLFP)
Hofer et alE48 2005 Case series INVOS RLFP for Norwood
procedure
10 Correlation of bilateral N
monitoring during RL
variable flow rates.
Andropoulos et alE49
(same patient
sample)þ
2004 Case series INVOS RLFP for Norwood
procedure or aortic arch
reconstruction
19 Correlation of bilateral N
monitoring during RL
adjusted for CBFV w
Hoffman et alE50 2004 Case series INVOS RLFP for Norwood
procedure
9 Relative changes in cere
somatic oxygenation d
RLFP adjusted for rSc
CBFV.
Kilpack et alE51
(same patient
sample)*
2004 Case series INVOS RLFP for Norwood
procedure or aortic arch
reconstruction
34 Demonstrate maintenanc
adequate rScO2 with R
when CPB flow adjus
rScO2 and CBFV.
Andropoulos et alE52
(same patient
sample)*
2003 Case series INVOS RLFP for Norwood
procedure or aortic arch
reconstruction
34 Describe the addition of
monitoring by TCD to
a guide to bypass flow
RLFP.
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TABLE E1. Continued
oint Results
ation
d on NIRS
Poor correlation between CBVI
and CBFV. Right sided CBFV
did not correlate with RLFP
flow rate.
vide
matic
s measured
Abdominal aortic blood pressure,
quadriceps blood volume, and
quadriceps rSO2 were
significantly greater during
RLFP than DHCA (P< .05).
sing NIRS
DHCA.
RLFP flow rate of 20 mL $ kg1 $
min1 maintained baseline
values. rScO2 and CBVI
decrease significantly during
DHCA but are maintained
during RLFP.
lood
B prime on
rScO2 decreases below baseline in
both groups at the start of CPB
andduring rewarming (P<.001)
with a greater reduction in the
bloodless prime group (P<.01).
H
nd SPCC.
rScO2 was significantly lower (P¼
.008) and the deoxyhgb was
significantly higher (p<0.0001)
with alpha-stat. SPCC was
significantly lower with pH-stat
(P< .0001).
old versus
of extent of
asured by
.
S100b increased significantly in
both groups. No correlation
between S100b and NIRS
measurements except lowest
post-CPB Cytaa3 level (P ¼
.016). TOI was significantly
impaired during rewarming.
f
on
FOE increases with the institution
of CPB in cyanotic patients.
FOE decreases during cooling
and only increases during
rewarming in the continuous
flow group. No significant
difference between groups at
any time in Cytaa3.
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irsch
et
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seAuthor Year Study design* Device Patient population Total number Primary end p
Andropoulos et alE53
(same patient sample)þ
2003 Case series INVOS RLFP for Norwood
procedure or aortic arch
reconstruction
20 Demonstrate the correl
between CBVI base
and CBFV by TCD.
Pigula et alE54 2001 Case series INVOS RLFP for Norwood
procedure or aortic arch
reconstruction
15 Ability of RLFP to pro
subdiaphragmatic so
circulatory support a
by somatic NIRS.
Pigula et alE55 2000 Case series INVOS/NIRO Neonatal aortic arch
reconstruction with RLFP
(n ¼ 6) and neonatal
cardiac repair with DHCA
(n ¼ 6)
12 Experiential report of u
guided RLFP versus
Perfusion techniques
Han et alE56 2004 Randomized INVOS Repair of ASD or VSD with
bloodless (n ¼ 18) or blood
(n ¼ 18) prime
36 Compare the effect of b
versus bloodless CP
rScO2.
Sakamato et alE57 2004 Randomized NIRO CPB in cyanotic patients using
alpha-stat (n ¼ 19) versus
pH-stat (n ¼ 21) strategy
40 Evaluate the effect of p
strategies on rScO2 a
Shaaban et alE58 2004 Case series NIRO Cold (25C) (n ¼ 9) versus warm
(35C) (n ¼ 9) CPB for
biventricular repair
18 Compare the effect of c
warm CPB in terms
cerebral damage (me
S100b) and oxyHgb
Wardle et alE59 1998 Case series NIRO Deep hypothermia (15C) (n ¼
15) versus mild–moderate
hypothermia (22–28C) (n ¼
15) CPB
30 Investigate the effect o
hypothermia and CA
cerebral FOE.
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TABLE E1. Continued
t Results
etween
ebral
ulsatile
CBF decreased by 36% per L $m2
$ min1 decrease in pump flow
rate regardless of pulsatility.
usate
rate,
rScO2 increases during cooling
(P<.001), rScO2 increased after
CPB was discontinued in the
low flow and low Hct group.
is
ingle
rScO2 at the end of the operation
was significantly lower in
patients who died (P ¼ .01),
rScO2 decreases significantly
after stage 1 palliation (P ¼
.001) and increases after stage 2
palliation (P ¼ .04). No
correlation with neurologic
complications.
anotic
efects.
Cerebral oxyHgb, deoxyHgb, and
total Hgb decrease and then
plateau on CPB. DeoxyHgb
and total Hbg decreased more
markedly in the cyanotic
patients (P< .01).
oups
seline
Preop rScO2 is lower in cyanotic
and noncyanotic infants with
left-to-right shunts (P< .01)
but not in cyanotic infants
without left-to-right shunts.
Periop death was associated
with a baseline rScO2<50%.
cerebral
al index
aving
Cerebral ischemia (defined as
abrupt decrease in both rScO2
and bispectral index with acute
hypotension) was more
common and frequent in
children<4 years. rScO2 was
more dependent on arterial
pressure in children<4 years.
Cerebral ischemia frequency
correlated negatively with Hct
(P< .0001).
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CHDAuthor Year Study design* Device Patient population Total number Primary end poin
Chow et alE60 1997 Randomized crossover NIRO CPB using pulsatile and
nonpulsatile flow
40 Examine the relationship b
pump flow rate and cer
hemodynamics during p
and nonpulsatile CPB.
Kurth et alE61 1997 Randomized NIMS CPB: warm (n¼ 10), hypothermic
(25C) (n ¼ 10), hypothermic/
low flow (n ¼ 9), and
hypothermic/low Hct (n ¼ 9)
38 Evaluate the effect of perf
temperature, pump flow
and Hct on cerebral O2
extraction.
Intraoperative monitoring
Fenton et al22 2007 Retrospective INVOS Single ventricle staged palliation
(n ¼ 34) and ductus-dependent
complete repair (n ¼ 12)
46 Determine whether rScO2
related to the stage of s
ventricle palliation.
Murayama et alE62 2006 Case series NIRO Repair of cyanotic (n ¼ 10) and
noncyanotic (n ¼ 10) heart
defects
20 Differences in rScO2 at the
initiation of CPB for cy
and noncyanotic heart d
Fenton et al20 2005 Retrospective INVOS Repair of cyanotic and
noncyanotic CHD
143 Determine CHD patient gr
with abnormally low ba
rScO2.
Hayashida et alE63 2004 Case series PSA-3N Noncyanotic CHD
repaired with CPB
65 Measure the incidence of
ischemia using bispectr
and NIRS in children h
cardiac surgery.
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point Results
cerebral
NIRS
.
OxyHgb decreases on CPB with
no change in deoxyHgb.
rebral
demand
RS.
rScO2 decreased by>15% in 10/
18 patients before cannulation
with cardiac manipulation.
rScO2 increases with the
institution of CPB and decays
at 0.25%/min at<20C
and 2%/min at>20C.
rScO2 varied inversely with
the rate of cooling
(P ¼ .04).
benefit of
on intraop
onitoring
) in
neurologic
length of
Of patients with neurologic
changes, significantly more
had noteworthy intraop
changes that were not
intervened on (P ¼ .003) with
significantly fewer of these
patients discharged from the
hospital within 1 week
(P< .05).
etween
sion and
No relation between arterial
oxygen tension and CBF. CBF
is associated with CPB flow
rate (decreases 4.2 fold per l/
m2/min).
s in cerebral
DHCA.
CBV decreased significantly with
cooling and increased
significantly with rewarming
(P<.001). CBV did not change
with pump flow rate or
MAP.
n CBV
nging PaCO2
sthesia and
c CPB.
CBVR is preserved under
anesthesia and hypothermic
CPB. The relationship
between CBV and PaCO2 is
linear.
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seTABLE E1. Continued
Author Year Study design* Device Patient population Total number Primary end
Morimoto et alE64 2003 Case series NIRO Repair of VSD 16 Examined changes in
oxygenation using
during VSD repair
Daubeney et alE65 1998 Case series INVOS Biventricular repair 18 Identify periods of ce
oxygen supply and
mismatch using NI
Austin et al18 1997 Retrospective INVOS CHD repair with CPB 250 Examine the potential
interventions based
neurophysiologic m
(TCD, EEG, NIRS
decreasing postop
complications and
hospital stay.
Chow et alE66 1997 Case series NIRO Noncyanotic CHD
repair with CPB
14 Explore the relation b
arterial oxygen ten
CBF during CPB.
Van Bel et alE67 1996 Case series Radiometer Neonatal and infant
CHD repair with CPB
12 Investigate the change
hemodynamics and
oxygenation during
Fallon et alE68 1994 Case series NIRO Elective CHD repair
with CPB
19 Measure the change i
associated with cha
(CBVR) under ane
during hypothermi
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point Results
in cerebral
ction of
In cyanotic patients, the total Hgb
decreased rapidly and then
reached a plateau, Cytaa3
decreased and oxyHgb index
increased. There were no
significant changes in the
noncyanotic patients. The
magnitude of the change in
Cytaa3 was associated with the
magnitude of change in total
Hgb (P< .0001). Signal
noise analysis raised concern
about the validity of the
results.
tor CBF, CBVR significantly decreased
during hypothermic (25C)
bypass.
s for preop
njuries and
nctional
roups
a secondary
TOI significantly decreased
during aortic XC in patients
with positive postop MRIs
(P ¼ .008).
I findings
oing
ure with
Prolonged low postop rScO2
(<45% for>180 minutes) was
associated with new or
worsening lesions (P ¼ .029)
with a positive predictive value
of 90% for positive MRI
findings.
ore, during,
itch
te its
velopmental
Recovery time for the EEG did not
correlate with normalization of
the rScO2. Complete recovery
of the rScO2 takes 6–72 hours
postop. Preop decrease in rScO2
tended to correlate with
decreased Bayley score but was
not significant.
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Author Year Study design* Device Patient population Total number Primary end
Skov and GreisenE69 1994 Case series Radiometer Biventricular cyanotic
(n ¼ 5) and noncyanotic
(n ¼ 9) CHD repair
with CPB
14 Examine the changes
cytaa3 during indu
CPB.
Fallon et alE70 1993 Case series NIRO Repair of CHD with CPB 13 Use of NIRS to moni
CBV, and CBVR.
Intraoperative combined with preoperative/postoperative monitoring
McQuillen et al21 2007 Case series NIRO Patients with CHD, preop/postop
MRI and intraop NIRS
16 Define the risk factor
and postop brain i
association with fu
cardiac anatomic g
(intraop NIRS was
analysis).
Dent et al19 2006 Case series INVOS Norwood procedure with RLFP,
preop/postop MRI, preop/
intraop/postop NIRS
22 Preop and postop MR
in neonates underg
a Norwood proced
RLFP.
Toet et al17 2005 Case series INVOS Transposition of the great arteries
repaired with DHCA, preop/
intraop/postop NIRS
20 Monitoring NIRS bef
and after arterial sw
operation to evalua
relation to neurode
outcomes.
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TABLE E1. Continued
Author Year Study design* Device Patient population Total number Primary end point Results
e series NIRO Repair of CHD with CPB 19 Describe a novel method to
measure CBF using
indocyanine green tracer with
NIRS.
11% variation between
measurements within
individual patients, 73% of the
variability was accounted for
by pump flow and temperature.
BF, cerebral blood flow; CBFV, cerebral blood flow velocity; CBV, cerebral blood volume; CBVI, cerebral blood volume index; CHD, congenital heart disease; CMRO2, cerebral
, deep hypothermic circulatory arrest; EEG, electroencephalography; FOE, fractional oxygen extraction; Hct, hematocrit; MAP, mean arterial pressure; MRI, magnetic resonance
, oxyhemoglobin; RLFP, regional low flow perfusion; rSO2, regional oxygen saturation; SPCC, systemic–pulmonary collateral circulation; TCD, transcranial Doppler; TOI, tissue
C, crossclamp. *Evidence Based Medicine Levels of Evidence: Level 1, systematic review of randomized controlled trials (RCTs), individual RCTs; level 2, systematic review of
dividual case control studies; level 4, case series; level 5, expert opinion.
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CHDMonitoring technique
Roberts et alE71 1998 Cas
ASD, Atrial septal defect; CA, circulatory arrest; C
metabolism; CPB, cardiopulmonary bypass; DHCA
imaging; NIRS, near-infrared spectroscopy; oxyHgb
oxygenation index; VSD, ventricular septal defect; X
cohort studies, individual cohort studies; level 3, in
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TABLE E2. NIRS monitoring in the intensive care unit
mary end point Results
erial changes in
ation state in the head
y in patients with
d pulmonary blood
With decreased SaO2 after the
initiation of hypoxia, cerebral
and brachial oxyHgb decreased
with an increase in deoxyHgb
hanges in rScO2 with
17% FIO2 or 3% CO2
Significant increase in rScO2 and
MAP with 3% CO2, no change
in rScO2 or MAP with 17%
FIO2
of rScO2 and CEO2
CHD patients and
rScO2 was significantly decreased
in patients with PDA, TOF,
HLHS, PA, SV with shunt, and
BDG but was the same for
VSD, CoA, and Fontan. CEO2
was significantly increased for
PDA and HLHS. SaO2 was
correlated with rScO2 but was
not a good substitute (R2 ¼.4)
ip between changes in
ith changes in regional
2 and central SvO2.
ed for 24 hours.
Central SvO2 was correlated with
rScO2 and flank rSO2 with wide
limits of agreement precluding
interchangeability. Changes in
PaCO2 and MAP were
associated with changes in
rScO2 but not flank rSO2 or
SvO2. Changes in SaO2 were
associated with SvO2 but not
rScO2.
of rScO2 to (1)
ntilation with increased
hyperventilation with
d RR, (3)
ntilation with decreased
nitoring for 4 hours.
(1) Increased pH, decreased PCO2,
and decreased rScO2; (2) same
as 1; (3) no change in pH,
increased PCO2, and increased
rScO2. Hyperventilation should
be avoided in patients with
BDG due to potential decrease
in rScO2.
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CHDAuthor Year Study design* Device Patient population Total number Pri
Preoperative ICU monitoring
Takami et al24 2005 Preop–postop NIRO CHD patients with
increased pulmonary
blood flow
8 Evaluate s
oxygen
and bod
increase
flow.
Ramamoorthy et al25 2002 Randomized
crossover
observational
NIM-prototype Single ventricle neonates 15 Evaluate c
inspired
Kurth et al23 2001 Case series NIM-prototype CHD and normal 110: 91 with CHD,
19 normal
Correlation
between
normals
Postoperative ICU monitoring
McQuillen et al26 2007 Case series INVOS Postop CHD patients 70 Relationsh
rScO2 w
flank SO
Monitor
Mott et al28 2006 Case series INVOS Bidirectional
Glenn (BDG)
10 Response
hyperve
TV, (2)
increase
hypove
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TABLE E2. Continued
int Results
cerebral
ren treated
s of
d
resistance.
r.
TOI increased significantly after
the first two doses but quickly
returned to baseline (P ¼ .01),
no change with the third dose.
There was no correlation
between cardiac index and TOI
bral and
g
stemic
n
t
tored for
rScO2 correlates with SaO2 and
PaO2 (P< .0001) with large
interindividual variation, rScO2
correlates with SvO2 (P<
.0001) with no interindividual
variation. Overall, large
interindividual variablity and
intraindividual temporal
variablity.
rameters
oxyHgb)
; identify
bral
neous
D and
higher
sure-
usion.
nd 20
Significant relationship between
change in CBFV and change in
HbD (P< .0001), also with
change in oxyHgb (P< .001).
13% of patients had disturbed
cerebral pressure
autoregulation at 6 hours that
persisted at 18 hours, high end
tidal CO2 was correlated with
pressure passive rather than
autoregulated cerebral
perfusion (P< .001)
O2
atric
le
s postop.
rScO2 correlated with SvO2 (P<
.001). There was low
intrasubject variation with
significant intersubject
variation; therefore cannot
predict absolute values but can
follow trends.
hip
lue for
lobal SvO2
n via
hours
TOI correlated with SvO2 (P<
.001). PaO2 (P ¼ .031), SaO2
(P ¼ .027), SBP (P ¼ .035),
and MAP (P ¼ .042). There
was no correlation with PaCO2,
heart rate, and hemoglobin.
H
irsch
et
a
l
C
o
n
g
en
ita
l
H
ea
rt
D
isea
seAuthor Year Study design* Device Patient population Total number Primary end po
Nagdyman et al30 2006 Case series NIRO Elevated pulmonary
vascular resistance
after CPB
13 Examine alterations in
oxygenation in child
with increasing dose
sildenafil for elevate
pulmonary vascular
Monitored for 1 hou
Li et al27 2006 Case series INVOS Postop Norwood pateints 11 Determine if NIRS cere
splanchnic monitorin
accurately reflects sy
oxygen delivery whe
compared with direc
measurements. Moni
72 hours.
Bassan et al29 2005 Case series NIRO Postop CHD patients 43 Correlation of NIRS pa
(HbD ¼ deoxyHgb–
with CBFV by TCD
pressure-passive cere
perfusion by simulta
measurements of Hb
MAP; and associate
CO2 levels with pres
passive cerebral perf
Measurements at 6 a
hours postop.
Tortoriello et al31 2005 Case series INVOS Elective postop
CHD patients
20 Compare rScO2 with Sv
(oximetry) after pedi
cardiac surgery. Sing
measurement 6 hour
Nagdyman et al32 2004 Case series NIRO Postop CHD patients 43 Determine the relations
between TOI as a va
regional rScO2 and g
(right atrial saturatio
central line). Single
measurement 2 to 3
postop.
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TABLE E2. Continued
Total number Primary end point Results
5 rScO2 on circulatory support after
SV repair
rScO2 levels dropped significantly
after separation from CPB and
remained 20% below baseline
for 24 hours and did not
normalize until 48 hours
despite stable SvO2, MAP, and
decreasing lactates.
oA, coarctation of the aorta; CPB, cardiopulmonary bypass; FIO2, inspired oxygen fraction; ICU, intensive
ary atresia; PDA, patent ductus arteriosus; RR, respiratory rate; rScO2, regional cerebral oxygen saturation;
n index; TV, tidal volume; VSD, ventricular septal defect. *Evidence Based Medicine Levels of Evidence:
dies, individual cohort studies; level 3, individual case control studies; level 4, case series; level 5, expert
C
o
n
g
en
ita
l
H
ea
rt
D
isea
se
H
irsch
et
a
l
1
5
9
.
CHDAuthor Year Study design* Device Patient population
Postoperative circulatory assist device monitoring
Giacomuzzi et al33 2005 Case series INVOS HLHS with postop circulatory
support
BDG, Bidirectional Glenn; CBFV, cerebral blood flow velocity; CEO2, cerebral O2 extraction; CHD, congenital heart disease; C
care unit; HLHS, hypoplastic left heart syndrome; MAP, mean arterial pressure; NIRS, near-infrared spectroscopy; PA, pulmon
SBP, systemic blood pressure; SV, single ventricle; TCD, transcranial Doppler; TOF, tetralogy of Fallot; TOI, tissue oxygenatio
Level 1, systematic review of randomized controlled trials (RCTs), individual RCTs; level 2, systematic review of cohort stu
opinion.
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TABLE E3. NIRS monitoring in the catheterization laboratory
Author Year Study design* Device Patient population Total number Primary end point Results
Correlation of rScO2 with IVC,
SVC, and PA SaO2 on RA and
100%
rScO2 correlates with SVC and PA
SaO2 on RA and 100%
Determine the best non-invasive
predictor of SVC SvO2 as
a marker of adequacy of
systemic oxygen delivery.
NIRS was a significant
independent predictor of SVC
SvO2 (P ¼ .000).
g)
Evaluate tissues saturation (NIRS-
deltoid) as a measure of SvO2
No correlation between tissue
saturation and SvO2
Correlation between tissue
oxygenation index (TOI) with
jugular SvO2 (SjO2)
SjO2 does correlates with TOI with
poor sensitivity of spatially
resolved spectroscopy
iac
)
Changes in cerebral
hemodynamics (TCD) and
oxygen metabolism (NIRS)
during balloon dilation
With balloon dilation, significant
decrease in velocity in the
MCA with no change in rScO2
group I, significant decrease in
rScO2 with no change in
velocity in the MCA group II.
Longer inflation time correlated
with longer time to recovery
Correlation of SaO2, rScO2, an SjO2
with normocapnia/FIO2 21%,
normocapnia/FIO2 100%,
hypocapnia/FIO2 21%
rScO2 correlates with SaO2 and
SjO2. The arterial to venous
ratio for rScO2 is consistent
within patients but varies
significantly between patients
Determine if rScO2 reflects jugular
bulb venous saturations.
Correlation between rScO2 and
jugular bulb SvO2 was 0.69
(P< .0001) with decreased
reliability at extremes.
roscopy; OHT, orthotopic heart transplantation; PA, pulmonary atresia; RA, radial artery;
index. *Evidence Based Medicine Levels of Evidence: Level 1, systematic review of ran-
case control studies; level 4, case series; level 5, expert opinion.
H
irsch
et
a
l
C
o
n
g
en
ita
l
H
ea
rt
D
isea
seBhutta et al34 2007 Case series INVOS OHT annual biopsy 29
Kirshbom et al38 2007 Case series INVOS Elective cardiac
catheterization in
single ventricle patients
20
Levy et al35 2005 Case series Inspectra Tissue
Spectrometer
Elective cardiac
catheterization
98 (50% with
intracardiac mixin
Nagdyman et al36 2005 Case series NIRO Elective cardiac
catheterization
60
de Vries et al40 2000 Case series INVOS Balloon dilation 11 (I: 6 no intracard
shunt, II: 5 with
intracardiac shunt
Watzman et al39 2000 Case series NIM-prototype Elective cardiac
catheterization
20
Daubeney et al 37 1996 Case series INVOS Pediatric CHD patients
in the cath lab (29) and
during cardiac surgery (11)
40
CHD, Congenital heart disease; FIO2, inspired oxygen fraction; IVC, inferior vena cava; MCA, main cerebral artery; NIRS, near-infrared spect
rScO2, regional cerebral oxygen saturation; SjO2, jugular SvO2; SVC, superior vena cava; TCD, transcranial Doppler; TOI, tissue oxygenation
domized controlled trials (RCTs), individual RCTs; level 2, systematic review of cohort studies, individual cohort studies; level 3, individual
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